Collagen I Antibody
Source: Rabbit mAb Catalog No. : CY5120
Collagen I Antibody (CY5120)
UniProt:P02452/P08123
Application:WB,IHC
Reactivity:Human,Cow
Source:Rabbit mAb
References（4）
http://www.abways.cn/showproduct.asp?cid=CY5120
数据表
-
UniProt
-
Mol Weight139kDa
-
Alternative NamesCollagen alpha-1(I) chain, Alpha-1 type I collagen, COL1A1;
-
ImmunogenA synthesized peptide derived from human Collagen I
-
StorageRabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
-
PurificationAffinity-chromatography
-
IsotypeRabbit IgG
-
ClonalityMonoclonal
-
DescriptionThis gene encodes one of the chains for type I collagen, the fibrillar collagen found in most connective tissues. Mutations in this gene are associated with osteogenesis imperfecta, Ehlers-Danlos syndrome, idiopathic osteoporosis, and atypical Marfan syndrome.
Applications
-
ReactivityHuman,Cow
-
ApplicationWB,IHC
-
Recommended dilutionWB 1:500~1:2000 IHC 1:50~1:200
-
Western blot analysis of Collagen I in Human stomach tissue lysate. -
Immunohistochemical analysis of paraffin-embedded human kidney, using Collagen I Antibody. -
Prostaglandin E1 Inhibited Diabetes-Induced Phenotypic Switching of Vascular Smooth Muscle Cells Through Activating Autophagy. -Cellular Physiology and Biochemistry -
Erjingwan Extracts Exert Antiaging Effects of Skin through Activating Nrf2 and Inhibiting NF-B. -Evidence-based Complementary and Alternative Medicine
引用文献（4条）
Prostaglandin E1 Inhibited Diabetes-Induced Phenotypic Switching of Vascular Smooth Muscle Cells Through Activating Autophagy.-Cellular Physiology and Biochemistry
Erjingwan Extracts Exert Antiaging Effects of Skin through Activating Nrf2 and Inhibiting NF-B.-Evidence-based Complementary and Alternative Medicine
Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice-Life Sciences
A Systematic Study of Traditional Chinese Medicine for the Treatment of Lung Adenocarcinoma Using a Reverse Network of Key Targets Based on Bioinformatics and Molecular Docking: Curcumin and Trans-Resveratrol as Potential Drug Candidates for Lung Adenocar
销售咨询
一键电话